03 November 1997
Coronary stent implantation results in patients treated with ticlopidine and aspirin
Maciej KośmiderMed Sci Monit 1997; 3(6): CR821-825 :: ID: 501788
Abstract
Antiplatelet drugs gradually replace anticoagulants in patients subjected to coronary artery stenting. The purpose of this paper is to present our own experiences associated with combined treatment with ticlopidine and aspirin. From June 1995 until December 1996 118 patients were subjected to placement of 127 coronary stents in our laboratory (including 58 PS, 52 GR II, 11 Wiktor and 6 NIR stents). The procedure was performed in planned course in 101 patients, while in 17 patients - in situation threatening of sudden occlusion of coronary artery (bail-out) or in its factual occurrence. All patients were treated with 10 000 IU of heparin IV, Aspirin 250 mg/day PO and Ticlopidine 2i250 mg. If the stent implantation was a planned course procedure, ticlopidine had been started three days before. If the decision was made during the angioplasty, the patient was treated with 500 mg during the procedure of stent placement. The drug was administered for 30 days unless side effects occurred. PS 153 and NIR stents were distended under high pressure of 16-18 Atm, Wiktor and GR II of 8-13 atm. No systematic ICUS control was conducted. None of the patients who had successful stent implantation had haemorrhagic complications or thrombosis symptoms. During 8-month follow-up period clinical symptoms of restenosis occurred in 10 cases, out of which 7 in the stent and 3 before or after it, as diagnosed on a control coronarography. Conclusion: Ticlopidine and Aspirin combined treatment provides good immediate and long term effect in coronary stent implantation, irrespective of the course of the procedure.
Keywords: Angioplasty, coronary stent implantation, antiplatelet treatment
493 1
Editorial
01 May 2023 : Editorial
Editorial: Twenty Years On from Sequencing the Human Genome, Personalized/Precision Oncology Prepares to Meet the Challenges of Checkpoint Inhibitor TherapyDOI: 10.12659/MSM.940911
Med Sci Monit 2023; 29:e940911
In Press
31 May 2023 : Review article
Prevalence, Diagnosis, and Management of Eclampsia and the Need for Improved Maternal Care: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.939919
30 May 2023 : Clinical Research
A Case-Control Study of Cognitive Function in Patients with End-Stage Renal Disease Before and After Hemodi...Med Sci Monit In Press; DOI: 10.12659/MSM.940409
30 May 2023 : Review article
A Review of the Role of the Zebrafish (Danio reiro) in Preclinical and Clinical Models of Biomarker Identif...Med Sci Monit In Press; DOI: 10.12659/MSM.940550
30 May 2023 : Database Analysis
The COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in PolandMed Sci Monit In Press; DOI: 10.12659/MSM.940904
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952